Zopiclone is a cyclopyrrolone sedative-hypnotic agent that modulates the GABA-A receptor complex, primarily indicated for the short-term treatment of insomnia. To support pharmaceutical quality control… Read more
![Chemical structure of (R)-6-(5-Chloropyridin-2-yl)-7-oxo-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-yl 4-methylpiperazine-1-carboxylate (S)-2-hydroxysuccinate](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F915038-31-2-R-6-5-Chloropyridin-2-yl-7-oxo-67-dihydro-5H-pyrrolo34-bpyrazin-5-yl-4-methylpiperazine-1-carboxylate-S-2-hydroxysuccinate.png&w=3840&q=75)








![Chemical structure of 6-(5-Chloropyridin-2-yl)- 6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5,7-dione](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F43200-82-4-6-5-Chloropyridin-2-yl-67-dihydro-5H-pyrrolo34-bpyrazin-57-dione.png&w=3840&q=75)
![Chemical structure of 6-(5-Chloropyridin-2-yl)-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-one](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F148891-53-6-6-5-Chloropyridin-2-yl-67-dihydro-5H-pyrrolo34-bpyrazin-5-one.png&w=3840&q=75)
![Chemical structure of 6-(5-Chloropyridin-2-yl)-7-oxo-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-yl 4-nitrosopiperazine-1-carboxylate](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F6-5-Chloropyridin-2-yl-7-oxo-67-dihydro-5H-pyrrolo34-bpyrazin-5-yl-4-nitrosopiperazine-1-carboxylate.png&w=3840&q=75)
![Chemical structure of 7-Chloromethyloxy-carbonyloxy-6-(5-chloropyridin-2-yl)-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-one](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F508169-18-4-7-Chloromethyloxy-carbonyloxy-6-5-chloropyridin-2-yl-67-dihydro-5H-pyrrolo34-bpyrazin-5-one.png&w=3840&q=75)
![Chemical structure of 7-Hydroxyfuro[3,4-b]pyrazin-5(7H)-one Diacetate](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F7-Hydroxyfuro34-bpyrazin-57H-one-Diacetate.png&w=3840&q=75)




































Zopiclone is a cyclopyrrolone sedative-hypnotic agent that modulates the GABA-A receptor complex, primarily indicated for the short-term treatment of insomnia. To support pharmaceutical quality control and research, this category provides a comprehensive range of reference standards, including the active parent drug, its pharmacopeial and non-pharmacopeial impurities, and synthetic intermediates. These materials are essential for impurity profiling, ensuring that process-related compounds and degradation products are identified and quantified in accordance with regulatory guidelines. Laboratories also utilize stable isotope labelled versions of Zopiclone and its metabolites as internal standards in liquid chromatography-tandem mass spectrometry (LC-MS/MS) to achieve high sensitivity and accuracy during method validation and stability studies. By maintaining strict control over related substances, such as synthetic precursors and degradation compounds, these analytical tools enable the precise characterization and verification of Zopiclone formulations throughout their lifecycle.